Product Roadmap
Our vision for the future of AI-enhanced medical imaging. We're continuously innovating to bring you the most advanced, safe, and effective imaging solutions.
Development Timeline
Our strategic roadmap for bringing DeepGAD™ to market and expanding its capabilities
FDA Submission
Complete FDA pre-submission meeting and prepare formal 510(k) submission for DeepGAD™ brain MRI application.
Market Launch
Launch DeepGAD™ for brain MRI with initial commercial deployments at select partner institutions.
Body MRI Expansion
Expand DeepGAD™ capabilities to body MRI applications including liver, kidney, and cardiac imaging.
International Expansion
Launch in European and Asia-Pacific markets with CE marking and local regulatory approvals.
Advanced Features
Introduce advanced AI features including real-time processing, automated quality assessment, and predictive analytics.
Future Vision (2026+)
Multi-Modal AI Platform
- • CT contrast dose reduction
- • PET radiotracer optimization
- • Ultrasound contrast enhancement
- • Multi-modal image fusion
Global Impact
- • Emerging market expansion
- • Cost-effective solutions
- • Telemedicine integration
- • Global health initiatives
Active Research Areas
Pediatric Applications
Specialized models for pediatric imaging with age-appropriate dose reduction protocols
Oncology Imaging
Enhanced contrast synthesis for tumor detection and treatment monitoring
Emergency Radiology
Rapid processing algorithms for emergency department imaging workflows
Stay Updated
Subscribe to our newsletter for the latest updates on product development and clinical trials